Abbas Tabatabaei, Eryen Nelson, Allison Glaser, Rebecca Ludwig, Julia Russell, Milind A. Phadnis, Michelle Drerup, Jared M. Bruce, Jeffrey M. Burns, Catherine F. Siengsukon
Objectives Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended non-pharmacological treatment for insomnia in adults; however, it remains unclear which older adults are most likely to benefit from CBT-I.Methods Data from a Randomized Controlled Trial (RCT) examining the effect of CBT-I on cognitive performance in older adults were used for this study.
Objectives Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended non-pharmacological treatment for insomnia in adults; however, it remains unclear which older adults are most likely to benefit from CBT-I.Methods Data from a Randomized Controlled Trial (RCT) examining the effect of CBT-I on cognitive performance in older adults were used for this study. Ninety-six older adults with insomnia received six weeks of CBT-I and were assessed at baseline, immediately following treatment, and at the 12-month follow-up. Ten baseline variables, including demographic, psychological, and sleep-related characteristics, were included in linear regression to examine their association with CBT-I success, defined as the Insomnia Severity Index (ISI) scores after six weeks of CBT-I and at the one-year follow-up.Results ISI significantly decreased following six weeks of CBT-I (Z = 8.3, p < .001) and remained significantly improved at the 12-month follow-up (Z = 8, p < .001). Higherbaseline sleep self-efficacy (β = −0.03, p < .02) and lower depression severity (β = 0.06, p = .04) were significantly associated with lower ISI scores immediately after CBT-I. Higherbaselinesleep self-efficacy was significantly associated (β = −0.03, p < .01) with lower ISI scores at the 12-month follow-up.Conclusion Six weeks of CBT-I resulted in significant and sustained reductions in insomnia severity in older adults. Baseline sleep self-efficacy and depression severity significantly predicted lower insomnia severity following CBT-I, whereas only sleep self-efficacy predicted the long-term maintenance of treatment gains. These findings underscore the importance of baseline sleep self-efficacy as key predictor for optimizing treatment planning and long-term outcomes.